The North America intraoperative neuromonitoring market is expected to reach US$ 1,874.02 million by 2027 from US$ 1,029.17 million in 2019; it is estimated to grow at a CAGR of 7.9% from 2020 to 2027.
Factors such as rising incidences of neurological disorders and increasing technological advancements in the field of neuromonitoring are expected to propel the growth of the market. However, lack of skilled professionals is the major factor hindering the market growth.
Intraoperative neurophysiological monitoring (IOM) is an integral part of most of the surgical procedures. It has been widely used to prevent the neurological damage caused during number of surgeries, identify neural structures and thereby prevent post-operative impairments. IOM employs a wide range of modalities, which includes motor evoked potentials (MEPs), somatosensory evoked potentials (SSEPs), electroencephalography (EEG), electromyography, brainstem auditory evoked potentials (BAEPs), and visual evoked potentials (VEPs).
Advancements in neuromonitoring have helped the surgeons minimize the risks during surgery when the central nervous system (CNS) is at risk. Many advanced products are being launched in the field of neuromonitoring, further driving the growth of the market. For instance, in February 2019, Alphatec Holdings Inc. has received 510(k) clearance from the FDA for its automated SafeOp neuromonitoring system. It offers real-time intraoperative nerve location and health assessment. To date, The SafeOp technology has been used in over 1,000 surgeries to identify nerve injury and has proved reliability in monitoring peripheral nerves in spine surgery.
Advancements in intraoperative neuromonitoring have resulted in the development of technologically advanced systems to improve patient monitoring during a surgical procedure. For instance, in February 2018, the Centers of Medicare & Medicaid Services approved SpineTRACK Registry by NuVasive, Inc. This device allows surgeons to use real-time data reports to make on-time medical decisions during surgeries. In addition, in October 2017, SpecialtyCare launched OptimizeOR, which is a robust operating room management analytics solution to help hospitals to improve their perioperative performance. Moreover, the market players in the market are also engaged in a strategic partnership with several companies to expand their geographic reach. For instance, in December 2017, NuVasive, Inc. acquired SafePassage, an intraoperative neuromonitoring service provider. This has strengthened the company’s IONM business.
North America is witnessing the growing number of COVID-19 cases; The patients suffering from critical surgeries such as spinal surgery, neurosurgery, and ENT surgery need physical attention and need to perform procedures in the clinics. The procedure includes Intraoperative Neuromonitoring, by systems, services and accessories. As the surgical treatment, procedures are directly contacted with patients’ that has a possible risk of infections, for the preventing the spread of COVID-19 it is requested to maintain social distancing as there is a greater risk of being infected with coronavirus due to direct exposure to oral fluids of the patients. Therefore, it is likely to affect the intraoperative neuromonitoring market owing to the above mention points.
Mexico Intraoperative neuromonitoring Market, Revenue and Forecast to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET SEGMENTATION
By Product
- Systems
- Accessories
- Services
By Source
- Insourced Monitoring
- Outsourced Monitoring
By Modality
- Motor Evoked Potentials
- Somatosensory Evoked Potentials
- Electroencephalography
- Electromyography
- Brainstem Auditory Evoked Potentials
- Visual Evoked Potentials
By Application
- Spinal Surgery
- Neurosurgery
- Vascular Surgery
- ENT Surgery
- Orthopedic Surgery
- Other Surgeries
By End User
- Hospitals
- Ambulatory Surgical Centers
By Country
- US
- Canada
- Mexico
Company Profiles
- Accurate Monitoring
- Computational Diagnostics, Inc
- IntraNerve Neuroscience Holdings, LLC
- Natus Medical Incorporated
- NuVasive, Inc
- SpecialtyCare
- Moberg Research, Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Source, Application, Modality, and End User, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Intraoperative Neuromonitoring Market – By Product
1.3.2 North America Intraoperative Neuromonitoring Market – By Source
1.3.3 North America Intraoperative neuromonitoring Market– By Application
1.3.4 North America Intraoperative neuromonitoring Market– By Modality
1.3.5 North America Intraoperative neuromonitoring Market– By End User
1.3.6 North America Intraoperative Neuromonitoring Market – By Country
2. North America Intraoperative Neuromonitoring Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Intraoperative Neuromonitoring Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Intraoperative Neuromonitoring Market - North America PEST Analysis
4.3 Expert Opinion
5. North America Intraoperative Neuromonitoring Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Rising Incidences of Neurological Disorders
5.1.2 Increasing Technological Advancements in the Field of Neuromonitoring
5.2 Key Market Restraints
5.2.1 Lack of Skilled Professionals
5.3 Key Market Opportunities
5.3.1 Increasing Research Activities in the Nerve Monitoring Field
5.4 Future Trends
5.4.1 Integration of Artificial Intelligence (AI) in Neuro-Monitoring
5.5 Impact analysis
6. Intraoperative Neuromonitoring Market – North America Analysis
6.1 North America Intraoperative neuromonitoring Market Revenue Forecasts and Analysis
7. North America Intraoperative Neuromonitoring Market Analysis and Forecasts To 2027 – By Product
7.1 Overview
7.2 North America Intraoperative Neuromonitoring Market, By Product 2019 & 2027 (%)
7.2.1 North America Intraoperative Neuromonitoring Market Revenue and Forecasts to 2027, By Product (US$ Mn)
7.3 Systems
7.3.1 Overview
7.3.2 North America Systems Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Accessories
7.4.1 Overview
7.4.2 North America Accessories Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Services
7.5.1 Overview
7.5.2 North America Services Market Revenue and Forecast to 2027 (US$ Mn)
8. North America Intraoperative Neuromonitoring Market Analysis and Forecasts To 2027 – By Source
8.1 Overview
8.2 North America Intraoperative Neuromonitoring Market, By Source 2019 & 2027 (%)
8.2.1 North America Intraoperative Neuromonitoring Market Revenue and Forecasts to 2027, By Source (US$ Mn)
8.3 Insourced Monitoring
8.3.1 Overview
8.3.2 North America Insourced Monitoring Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Outsourced Monitoring
8.4.1 Overview
8.4.2 North America Outsourced Monitoring Market Revenue and Forecasts to 2027 (US$ Mn)
9. North America Intraoperative Neuromonitoring Market Analysis and Forecasts To 2027 – By Application
9.1 Overview
9.2 North America Intraoperative Neuromonitoring Market, By Application 2019 & 2027 (%)
9.2.1 North America Intraoperative Neuromonitoring Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.3 Spinal Surgery
9.3.1 Overview
9.3.2 North America Spinal Surgery Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Neurosurgery
9.4.1 Overview
9.4.2 North America Neurosurgery Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Vascular Surgery
9.5.1 Overview
9.5.2 North America Vascular Surgery Market Revenue and Forecast to 2027 (US$ Mn)
9.6 ENT Surgery
9.6.1 Overview
9.6.2 North America ENT Surgery Market Revenue and Forecast to 2027 (US$ Mn)
9.7 Orthopaedic Surgery
9.7.1 Overview
9.7.2 North America Orthopaedic Surgery Market Revenue and Forecasts to 2027 (US$ Mn)
9.8 Other Surgeries
9.8.1 Overview
9.8.2 North America Other Surgeries Market Revenue and Forecast to 2027 (US$ Mn)
10. North America Intraoperative Neuromonitoring Market Analysis and Forecasts To 2027 – By Modality
10.1 Overview
10.2 North America Intraoperative Neuromonitoring Market, By Modality 2019 & 2027 (%)
10.2.1 North America Intraoperative Neuromonitoring Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
10.3 Somatosensory Evoked Potentials
10.3.1 Overview
10.3.2 North America Somatosensory Evoked Potentials Market Revenue and Forecast to 2027 (US$ Mn)
10.4 Motor Evoked Potentials
10.4.1 Overview
10.4.2 North America Motor Evoked Potentials Market Revenue and Forecasts to 2027 (US$ Mn)
10.5 Electromyography
10.5.1 Overview
10.5.2 North America Electromyography Market Revenue and Forecast to 2027 (US$ Mn)
10.6 Electroencephalography
10.6.1 Overview
10.6.2 North America Electroencephalography Market Revenue and Forecasts to 2027 (US$ Mn)
10.7 Brainstem Auditory Evoked Potentials
10.7.1 Overview
10.7.2 North America Brainstem Auditory Evoked Potentials Market Revenue and Forecast to 2027 (US$ Mn)
10.8 Visual Evoked Potentials
10.8.1 Overview
10.8.2 North America Visual Evoked Potentials Market Revenue and Forecasts to 2027 (US$ Mn)
11. North America Intraoperative Neuromonitoring Market Analysis – By End-User
11.1 Overview
11.2 North America Intraoperative Neuromonitoring Market, By End-User 2019-2027 (%)
11.2.1 North America Intraoperative neuromonitoring Market Revenue and Forecasts to 2027, By End-User (US$ Mn)
11.3 Hospitals
11.3.1 Overview
11.3.2 North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
11.4 Ambulatory Surgical Centers
11.4.1 Overview
11.4.2 North America Academic Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
12. Intraoperative neuromonitoring Market Revenue and Forecasts To 2027 – Geographical Analysis
12.1 North America Intraoperative neuromonitoring Market Revenue and Forecasts To 2027
12.1.1 North America: Intraoperative Neuromonitoring Market – Revenue and Forecast to 2027 (USD Million)
12.1.2 North America Intraoperative Neuromonitoring Market, by Product – Revenue and Forecast to 2027 (USD Million)
12.1.3 North America Intraoperative Neuromonitoring Market, by Source– Revenue and Forecast to 2027 (USD Million)
12.1.4 North America Intraoperative Neuromonitoring Market, by Application – Revenue and Forecast to 2027 (USD Million)
12.1.5 North America Intraoperative Neuromonitoring Market, by Modality – Revenue and Forecast to 2027 (USD Million)
12.1.6 North America Intraoperative Neuromonitoring Market, by End User – Revenue and Forecast to 2027 (USD Million)
12.1.7 North America: Intraoperative Neuromonitoring Market, by Country, 2019 & 2027 (%)
12.1.8 US: Intraoperative Neuromonitoring Market – Revenue and Forecast to 2027 (USD Million)
12.1.8.1 US: Intraoperative Neuromonitoring Market – Revenue and Forecast to 2027 (USD Million)
12.1.8.2 US Intraoperative Neuromonitoring Market, by Product – Revenue and Forecast to 2027 (USD Million)
12.1.8.3 US Intraoperative Neuromonitoring Market, by Source– Revenue and Forecast to 2027(USD Million)
12.1.8.4 US Intraoperative Neuromonitoring Market, by Application – Revenue and Forecast to 2027 (USD Million)
12.1.8.5 US Intraoperative Neuromonitoring Market, by Modality – Revenue and Forecast to 2027 (USD Million)
12.1.8.6 US Intraoperative Neuromonitoring Market, by End User – Revenue and Forecast to 2027 (USD Million)
12.1.9 Canada: Intraoperative Neuromonitoring Market – Revenue and Forecast to 2027 (USD Million)
12.1.9.1 Canada: Intraoperative Neuromonitoring Market – Revenue and Forecast to 2027 (USD Million)
12.1.9.2 Canada Intraoperative Neuromonitoring Market, by Product – Revenue and Forecast to 2027 (USD Million)
12.1.9.3 Canada Intraoperative Neuromonitoring Market, by Source– Revenue and Forecast to 2027(USD Million)
12.1.9.4 Canada Intraoperative Neuromonitoring Market, by Application – Revenue and Forecast to 2027 (USD Million)
12.1.9.5 Canada Intraoperative Neuromonitoring Market, by Modality – Revenue and Forecast to 2027 (USD Million)
12.1.9.6 Canada Intraoperative Neuromonitoring Market, by End User – Revenue and Forecast to 2027 (USD Million)
12.1.10 Mexico: Intraoperative Neuromonitoring Market – Revenue and Forecast to 2027 (USD Million)
12.1.10.1 Mexico: Intraoperative Neuromonitoring Market – Revenue and Forecast to 2027 (USD Million)
12.1.10.2 Mexico Intraoperative Neuromonitoring Market, by Product – Revenue and Forecast to 2027 (USD Million)
12.1.10.3 Mexico Intraoperative Neuromonitoring Market, by Source– Revenue and Forecast to 2027(USD Million)
12.1.10.4 Mexico Intraoperative Neuromonitoring Market, by Application – Revenue and Forecast to 2027 (USD Million)
12.1.10.5 Mexico Intraoperative Neuromonitoring Market, by Modality – Revenue and Forecast to 2027 (USD Million)
12.1.10.6 Mexico Intraoperative Neuromonitoring Market, by End User – Revenue and Forecast to 2027 (USD Million)
13. Impact of COVID-19 Pandemic on North America Intraoperative neuromonitoring Market
13.1 North America: Impact Assessment of COVID-19 Pandemic
14. Company Profiles
14.1 Accurate Monitoring
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Computational Diagnostics, Inc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 IntraNerve Neuroscience Holdings, LLC
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Natus Medical Incorporated
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 NuVasive, Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 SpecialtyCare
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Moberg Research, Inc.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
15. Appendix
15.1 About the Insight Partners
15.2 Word Index
LIST OF TABLES
Table 1. North America Intraoperative Neuromonitoring Market Revenue and Forecasts To 2027, By Product (US$ Mn)
Table 2. North America Intraoperative Neuromonitoring Market Revenue and Forecasts To 2027, By Source (US$ Mn)
Table 3. North America Intraoperative Neuromonitoring Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 4. North America Intraoperative Neuromonitoring Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
Table 5. North America Intraoperative neuromonitoring Market Revenue and Forecasts To 2027, By End-User (US$ Mn)
Table 6. North America Intraoperative Neuromonitoring Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 7. North America Intraoperative Neuromonitoring Market, by Source– Revenue and Forecast to 2027(USD Million)
Table 8. North America Intraoperative Neuromonitoring Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 9. North America Intraoperative Neuromonitoring Market, by Modality – Revenue and Forecast to 2027 (USD Million)
Table 10. North America Intraoperative Neuromonitoring Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 11. US Intraoperative Neuromonitoring Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 12. US Intraoperative Neuromonitoring Market, by Source– Revenue and Forecast to 2027(USD Million)
Table 13. US Intraoperative Neuromonitoring Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 14. US Intraoperative Neuromonitoring Market, by Modality – Revenue and Forecast to 2027 (USD Million)
Table 15. US Intraoperative Neuromonitoring Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 16. Canada Intraoperative Neuromonitoring Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 17. Canada Intraoperative Neuromonitoring Market, by Source– Revenue and Forecast to 2027(USD Million)
Table 18. Canada Intraoperative Neuromonitoring Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 19. Canada Intraoperative Neuromonitoring Market, by Modality – Revenue and Forecast to 2027 (USD Million)
Table 20. Canada Intraoperative Neuromonitoring Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 21. Mexico Intraoperative Neuromonitoring Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 22. Mexico Intraoperative Neuromonitoring Market, by Source– Revenue and Forecast to 2027(USD Million)
Table 23. Mexico Intraoperative Neuromonitoring Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 24. Mexico Intraoperative Neuromonitoring Market, by Modality – Revenue and Forecast to 2027 (USD Million)
Table 25. Mexico Intraoperative Neuromonitoring Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 26. List of Abbreviation
LIST OF FIGURES
Figure 1. Intraoperative Neuromonitoring Market Segmentation
Figure 2. North America Intraoperative Neuromonitoring Market Overview
Figure 3. The Systems Segment Held Largest Share of Intraoperative neuromonitoring Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. North America Intraoperative Neuromonitoring Market - Leading Country Markets (US$ Mn)
Figure 6. Intraoperative Neuromonitoring Market - North America PEST Analysis
Figure 7. Intraoperative Neuromonitoring Market Impact Analysis of Driver and Restraints
Figure 8. North America Intraoperative neuromonitoring Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. North America Intraoperative Neuromonitoring Market, By Product 2019 & 2027 (%)
Figure 10. North America Systems Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. North America Accessories Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. North America Services Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. North America Intraoperative Neuromonitoring Market, By Source 2019 & 2027 (%)
Figure 14. North America Insourced Monitoring Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. North America Outsourced Monitoring Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. North America Intraoperative Neuromonitoring Market, By Application 2019 & 2027 (%)
Figure 17. North America Spinal Surgery Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. North America Neurosurgery Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. North America Vascular Surgery Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. North America ENT Surgery Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. North America Orthopaedic Surgery Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. North America Other Surgeries Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. North America Intraoperative Neuromonitoring Market, By Modality 2019 & 2027 (%)
Figure 24. North America Somatosensory Evoked Potentials Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. North America Motor Evoked Potentials Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. North America electromyography Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. North America Electroencephalography Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 28. North America Brainstem Auditory Evoked Potentials Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. North America Visual Evoked Potentials Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. North America Intraoperative Neuromonitoring Market, by End-User 2019 & 2027 (%)
Figure 31. North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 32. North America Academic Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 33. North America: Intraoperative Neuromonitoring Market, by Key Country – Revenue (2019) (USD Million)
Figure 34. North America Intraoperative Neuromonitoring Market Revenue and Forecast to 2027 (USD Million)
Figure 35. North America: Intraoperative Neuromonitoring Market, by Country, 2019 & 2027 (%)
Figure 36. US: Intraoperative Neuromonitoring market – Revenue and Forecast to 2027 (USD Million)
Figure 37. Canada: Intraoperative Neuromonitoring Market – Revenue and Forecast to 2027 (USD Million)
Figure 38. Mexico: Intraoperative Neuromonitoring Market – Revenue and Forecast to 2027 (USD Million)
Figure 39. Impact of COVID-19 Pandemic in North American Country Markets
The List of Companies - North America Intraoperative Neuromonitoring Market
- Accurate Monitoring
- Computational Diagnostics, Inc
- IntraNerve Neuroscience Holdings, LLC
- Natus Medical Incorporated
- NuVasive, Inc
- SpecialtyCare
- Moberg Research, Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to North America Intraoperative Neuromonitoring Market
Sep 2020
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Sep 2020
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Sep 2020
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)